Aptevo Therapeutics Inc (APVO)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Marvin L. White
Employees:
50
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
206-838-0500
Date | Ratio |
---|---|
2020-03-27 | 1:14 |
2024-03-06 | 1:44 |
Aptevo Therapeutics Inc. focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company also has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|